Dr. Lal Path Labs Ltd.: General Updates

General Updates - Dr. Lal Path Labs Ltd. has informed the Exchange about acquisition of 70% stake in SN Genelab Private Limited ( S N Gene ) from its existing Shareholders. Post acquisition, S N Gene shall become a Subsidiary of the Company

Sources

• NSE filing - Dr. Lal Path Labs Ltd. · official

Related deals

• Rajani Associates advises Wanbury on ₹205 crore redemption of debentures31 Aug 2026 · ₹205 cr
• Cyril Amarchand Mangaldas, Khaitan & Co act on Horizon Industrial Parks ₹2,600 crore IPO31 Aug 2026 · ₹2,600 cr
• CMS INDUSLAW, SAM, TT&A, CAM act on Yulu Bikes $93 million Series C fundraise31 Aug 2026 · $93 mn
• Piramal Finance Limited: Press Release31 Aug 2026 · ₹3,850 cr
• Welspun Living Limited: General Updates31 Aug 2026
• Tribhovandas Bhimji Zaveri Limited: Public Announcement-Open Offer31 Aug 2026